These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30530228)

  • 1. Neuroprotection and improvement of the histopathological and behavioral impairments in a murine Alzheimer's model treated with Zephyranthes carinata alkaloids.
    Cortes N; Sabogal-Guaqueta AM; Cardona-Gomez GP; Osorio E
    Biomed Pharmacother; 2019 Feb; 110():482-492. PubMed ID: 30530228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective activity and acetylcholinesterase inhibition of five Amaryllidaceae species: a comparative study.
    Cortes N; Posada-Duque RA; Alvarez R; Alzate F; Berkov S; Cardona-Gómez GP; Osorio E
    Life Sci; 2015 Feb; 122():42-50. PubMed ID: 25529145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amaryllidaceae alkaloids as agents with protective effects against oxidative neural cell injury.
    Cortes N; Castañeda C; Osorio EH; Cardona-Gomez GP; Osorio E
    Life Sci; 2018 Jun; 203():54-65. PubMed ID: 29679699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms.
    Giuliani D; Ottani A; Zaffe D; Galantucci M; Strinati F; Lodi R; Guarini S
    Neurobiol Learn Mem; 2013 Sep; 104():82-91. PubMed ID: 23726868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
    Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
    Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Effects of Palmitoylethanolamide against Amyloid-β Induced Toxicity in Cortical Neuronal and Astrocytic Primary Cultures from Wild-Type and 3xTg-AD Mice.
    Tomasini MC; Borelli AC; Beggiato S; Ferraro L; Cassano T; Tanganelli S; Antonelli T
    J Alzheimers Dis; 2015; 46(2):407-21. PubMed ID: 25765918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artemether Activation of AMPK/GSK3
    Li S; Zhao X; Lazarovici P; Zheng W
    Oxid Med Cell Longev; 2019; 2019():1862437. PubMed ID: 31871541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice.
    Sabogal-Guáqueta AM; Muñoz-Manco JI; Ramírez-Pineda JR; Lamprea-Rodriguez M; Osorio E; Cardona-Gómez GP
    Neuropharmacology; 2015 Jun; 93():134-45. PubMed ID: 25666032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer's disease.
    Park JS; Kam TI; Lee S; Park H; Oh Y; Kwon SH; Song JJ; Kim D; Kim H; Jhaldiyal A; Na DH; Lee KC; Park EJ; Pomper MG; Pletnikova O; Troncoso JC; Ko HS; Dawson VL; Dawson TM; Lee S
    Acta Neuropathol Commun; 2021 Apr; 9(1):78. PubMed ID: 33902708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocytic palmitoylethanolamide pre-exposure exerts neuroprotective effects in astrocyte-neuron co-cultures from a triple transgenic mouse model of Alzheimer's disease.
    Beggiato S; Cassano T; Ferraro L; Tomasini MC
    Life Sci; 2020 Sep; 257():118037. PubMed ID: 32622942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipotassium N-stearoyltyrosinate ameliorated pathological injuries in triple-transgenic mouse model of Alzheimer's disease.
    Liu S; Tang SQ; Cui HJ; Yin S; Yin M; Zhao H; Meng LH; Wang ZJ; Lu Y
    J Pharmacol Sci; 2016 Sep; 132(1):92-99. PubMed ID: 27671351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
    Huang M; Jiang X; Liang Y; Liu Q; Chen S; Guo Y
    Exp Gerontol; 2017 May; 91():25-33. PubMed ID: 28223223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of COX1-2/5-LOX blockade in Alzheimer transgenic 3xTg-AD mice.
    Bitto A; Giuliani D; Pallio G; Irrera N; Vandini E; Canalini F; Zaffe D; Ottani A; Minutoli L; Rinaldi M; Guarini S; Squadrito F; Altavilla D
    Inflamm Res; 2017 May; 66(5):389-398. PubMed ID: 28238167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linalool reverses neuropathological and behavioral impairments in old triple transgenic Alzheimer's mice.
    Sabogal-Guáqueta AM; Osorio E; Cardona-Gómez GP
    Neuropharmacology; 2016 Mar; 102():111-20. PubMed ID: 26549854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Huprine X and huperzine A improve cognition and regulate some neurochemical processes related with Alzheimer's disease in triple transgenic mice (3xTg-AD).
    Ratia M; Giménez-Llort L; Camps P; Muñoz-Torrero D; Pérez B; Clos MV; Badia A
    Neurodegener Dis; 2013; 11(3):129-40. PubMed ID: 22626981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of Hydrogen Sulfide against the Progression of Severe Alzheimer's Disease in Transgenic Mice at Different Ages.
    Vandini E; Ottani A; Zaffe D; Calevro A; Canalini F; Cavallini GM; Rossi R; Guarini S; Giuliani D
    Pharmacology; 2019; 103(1-2):50-60. PubMed ID: 30448835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a 3xTg-AD mouse model of Alzheimer's disease with the senescence accelerated mouse prone 8 (SAMP8) background.
    Virgili J; Lebbadi M; Tremblay C; St-Amour I; Pierrisnard C; Faucher-Genest A; Emond V; Julien C; Calon F
    Synapse; 2018 Apr; 72(4):. PubMed ID: 29341269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.